Peak6 Investments LLC Horizon Therapeutics Public LTD CO Call Options Transaction History

Peak6 Investments LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 13, 2023	SELL	$98.98 - $115.74 $2.69 Million - $3.15 Million	-27,200 Reduced 41.46%	38,400 $4.44 Million
Q2 2023 Aug 11, 2023	BUY	$96.34 - $112.38 $6.32 Million - $7.37 Million	65,600 New	65,600 $6.75 Million
Q4 2022 Feb 10, 2023	BUY	$62.39 - $113.8 $124,780 - $227,600	2,000 New	2,000 $228,000
Q2 2022 Aug 12, 2022	SELL	$79.4 - $116.36 $6.78 Million - $9.94 Million	-85,400 Reduced 97.05%	2,600 $207,000
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $4.92 Million - $6.25 Million	56,900 Added 182.96%	88,000 $9.26 Million

Q4 2021 Feb 11, 2022	BUY	$98.56 - $119.91 $2.03 Million - $2.47 Million	20,600 Added 196.19%	31,100 $3.35 Million
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $965,055 - $1.16 Million	10,500 New	10,500 $1.15 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Peak6 Investments LLC with notifications on news.